SCHEMBL30400272

SCHEMBL30400272

O=C(Nc1cnn(C2CCNCC2)c1)c1cnc2[nH]cc(-c3ccc4ncccc4c3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.48
▸ ERBB2 P04626 1/20 0.48
▸ ERBB4 Q15303 1/20 0.48
▸ DYRK1A Q13627 6/20 0.46
▸ CLK1 P49759 2/20 0.46
▸ DYRK1B Q9Y463 2/20 0.46
▸ PAK1 Q13153 7/20 0.46
▸ EIF2AK4 Q9P2K8 4/20 0.46
▸ PAK4 O96013 2/20 0.45
▸ DYRK2 Q92630 1/20 0.45
▸ MAPK7 Q13164 1/20 0.44
▸ GSK3B P49841 3/20 0.43
▸ GRK2 P25098 1/20 0.43
▸ GRK5 P34947 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175108 1.00 EGFR (0.48) EGFRERBB2ERBB4DYRK1ACLK1
SCHEMBL26175148 0.91 FLT3 (0.48) DYRK1ACLK1DYRK1BDYRK2MAPK7
SCHEMBL30398955 0.91 FLT3 (0.48) DYRK1ACLK1DYRK1BDYRK2MAPK7
SCHEMBL30399658 0.91 DYRK1A (0.48) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL26175109 0.91 DYRK1A (0.48) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL26175110 0.89 DYRK1A (0.46) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL30399049 0.89 DYRK1A (0.46) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL30399310 0.87 DYRK1A (0.48) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL26175076 0.87 DYRK1A (0.48) DYRK1ACLK1DYRK1BPAK1PAK4
SCHEMBL26175092 0.84 PAK1 (0.46) DYRK1ACLK1DYRK1BPAK1PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback